These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 8770844)

  • 1. Drug variables in thrombolytic therapy.
    Meyerovitz MF
    J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):62S-65S. PubMed ID: 8770844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic agents for peripheral arterial occlusion.
    Robertson I; Kessel DO; Berridge DC
    Cochrane Database Syst Rev; 2013 Dec; (12):CD001099. PubMed ID: 24357258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic agents for peripheral arterial occlusion.
    Robertson I; Kessel DO; Berridge DC
    Cochrane Database Syst Rev; 2010 Mar; (3):CD001099. PubMed ID: 20238313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombolytic therapy of deep venous thrombosis. Indications, treatment procedures].
    Theiss W
    Internist (Berl); 1992 Apr; 33(4):225-31. PubMed ID: 1612846
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of streptokinase and urokinase in local thrombolysis of peripheral arterial occlusions for lower limb salvage.
    Dubé M; Soulez G; Thérasse E; Cartier P; Blair JF; Roy P; Robillard P; Bruneau L; Van Nguyen P; Cusson JR
    J Vasc Interv Radiol; 1996; 7(4):587-93. PubMed ID: 8855542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinations of thrombolytic agents in acute myocardial infarction.
    Bode C; Baumann H; von Hodenberg E; Freitag M; Nordt T
    Z Kardiol; 1993; 82 Suppl 2():125-8. PubMed ID: 8328189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrinolytic therapy in ischemic brain infarct].
    Del Zoppo GJ; Hacke W
    Dtsch Med Wochenschr; 1987 Apr; 112(15):603-8. PubMed ID: 3104001
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biochemical, pharmacologic and clinical properties of new thrombolytic agents].
    Gulba DC
    Internist (Berl); 1996 Jun; 37(6):552-66. PubMed ID: 8767988
    [No Abstract]   [Full Text] [Related]  

  • 9. Evolving strategies for thrombolytic therapy of peripheral vascular occlusion.
    Valji K
    J Vasc Interv Radiol; 2000 Apr; 11(4):411-20. PubMed ID: 10787198
    [No Abstract]   [Full Text] [Related]  

  • 10. Intraarterial fibrinolysis: in vitro and prospective clinical evaluation of three thrombolytic agents.
    Pilger E; Lammer J; Bertuch H; Steiner H
    Radiology; 1986 Dec; 161(3):597-9. PubMed ID: 3786705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis in newborns and infants.
    Nowak-Göttl U; Auberger K; Halimeh S; Junker R; Klinge J; Kreuz WD; Ries M; Schlegel N
    Thromb Haemost; 1999 Sep; 82 Suppl 1():112-6. PubMed ID: 10695499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of thrombolytic therapy in vascular occlusive disease. A surgical view.
    Towne JB; Bandyk DF
    Am J Surg; 1987 Nov; 154(5):548-59. PubMed ID: 3118728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The results of arterial thrombolysis.
    Kroese AJ; Staxrud LE
    Ann Chir Gynaecol; 1995; 84(4):350-3. PubMed ID: 8687078
    [No Abstract]   [Full Text] [Related]  

  • 15. Peripheral arteries: treatment with antibodies of platelet receptors and reteplase for thrombolysis--APART trial.
    Tepe G; Hopfenzitz C; Dietz K; Wiskirchen J; Heller S; Ouriel K; Ziemer G; Claussen CD; Duda SH
    Radiology; 2006 Jun; 239(3):892-900. PubMed ID: 16641342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolytic therapy for pulmonary embolism.
    Katchan BM
    Can J Surg; 2000 Dec; 43(6):411-6. PubMed ID: 11129828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolysis: a Misunderstood Natural Defense Whose Therapeutic Potential Is Unknown.
    Gurewich V
    Cardiovasc Drugs Ther; 2019 Dec; 33(6):749-753. PubMed ID: 31897763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy in peripheral arterial occlusive disease: mechanisms of action and drugs available.
    Comerota AJ; Cohen GS
    Can J Surg; 1993 Aug; 36(4):342-8. PubMed ID: 8370015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic agents in critical care.
    Weiner B
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):355-66. PubMed ID: 8398041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study.
    Ouriel K; Katzen B; Mewissen M; Flick P; Clair DG; Benenati J; McNamara TO; Gibbens D
    J Vasc Interv Radiol; 2000; 11(7):849-54. PubMed ID: 10928520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.